Hims and Hers Launches Generic Semaglutide in Canada
Hims and Hers Health has launched generic semaglutide in Canada via its telehealth platform. The Apotex-made drug will start at 149 Canadian dollars per month.
Xurve View
Insights:
Xurve View
Hims & Hers Health Inc began offering a generic version of semaglutide in Canada on Thursday. The telehealth provider is leveraging the patent expiry of Novo Nordisk A/S-B to launch its first international GLP-1 weight-loss offering. This expansion allows the firm to capture market share in a high-demand category with pricing 25% lower than the minimum cost of branded alternatives.
